Ask AI
Bill115th CongressFiled May 11, 2018Health
H.R. 5775

PROPER Act of 2018

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house amended (Jun 19, 2018)

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

(Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

(Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

(Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

What just happenedJun 20, 2018

Received in the Senate and Read twice and referred to the Committee on Finance.

Who’s behind it

Rep. Paulsen, Erik [R-MN-3](R-MN)Sponsor
5 cosponsors2 D3 R
Read on Congress.gov
5cosponsors3committees19actions5related bills17subjects
  1. Jun 20, 2018IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Finance.

    Finance Committee
  2. Jun 19, 2018FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Jun 19, 2018FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)

  4. Jun 19, 2018Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)

  5. Jun 19, 2018FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.

  6. Jun 19, 2018FloorH30000

    Considered under suspension of the rules. (consideration: CR H5256-5258)

  7. Jun 19, 2018FloorH30300

    Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.

  8. Jun 19, 2018CalendarsH12410

    Placed on the Union Calendar, Calendar No. 594.

  9. Jun 19, 2018DischargeH12300

    Committee on Energy and Commerce discharged.

    Energy and Commerce Committee
  10. Jun 19, 2018Committee5500

    Committee on Energy and Commerce discharged.

    Energy and Commerce Committee
  11. Jun 19, 2018CommitteeH12200

    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.

    Ways and Means Committee
  12. Jun 19, 2018Committee5000

    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.

    Ways and Means Committee
  13. Jun 4, 2018Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  14. May 16, 2018Committee

    Ordered to be Reported (Amended) by Voice Vote.

    Ways and Means Committee
  15. May 16, 2018Committee

    Committee Consideration and Mark-up Session Held.

    Ways and Means Committee
  16. May 11, 2018IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  17. May 11, 2018IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  18. May 11, 2018IntroReferralIntro-H

    Introduced in House

  19. May 11, 2018IntroReferral1000

    Introduced in House

Passed House amendedJun 19, 201836

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

(Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

(Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

(Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

Introduced in HouseMay 11, 2018

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

PROPER Act of 2018 — Informed